Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 29 most recent Form 4 transactions.
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,184 | $53.42 | $116.7K | -8.0% | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,063 | $52.39 | $108.1K | -7.0% | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 459 | $51.55 | $23.7K | -1.5% | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 231 | $50.05 | $11.6K | -0.8% | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Jun 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,133 | $44.74 | $50.7K | -4.3% | Open the original filing on SEC.gov |
| Jun 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,599 | $43.87 | $114K | -9.0% | Open the original filing on SEC.gov |
| Jun 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,268 | $42.83 | $54.3K | -4.2% | Open the original filing on SEC.gov |
| Jun 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Jun 4 | KURA | Kura Oncology, Inc. | AGRANT◆ | 35,000 | — | — | — | Open the original filing on SEC.gov |
| May 18 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| May 18 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 223 | $41.21 | $9.2K | -0.9% | Open the original filing on SEC.gov |
| May 18 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,302 | $40.25 | $52.4K | -4.9% | Open the original filing on SEC.gov |
| May 18 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 3,475 | $39.53 | $137.4K | -11.6% | Open the original filing on SEC.gov |
| May 18 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Apr 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,441 | $48.06 | $117.3K | -8.9% | Open the original filing on SEC.gov |
| Apr 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,419 | $47.39 | $114.6K | -8.1% | Open the original filing on SEC.gov |
| Apr 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 140 | $45.81 | $6.4K | -0.5% | Open the original filing on SEC.gov |
| Apr 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Mar 25 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 25 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 40,000 | $35.10 | $1.4M | -61.5% | Open the original filing on SEC.gov |
| Mar 25 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 40,000 | $2.48 | $99.2K | +160.0% | Open the original filing on SEC.gov |
| Mar 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 5,000 | $27.76 | $138.8K | -16.7% | Open the original filing on SEC.gov |
| Mar 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |